Nuvectis Pharma Inc. - Rasio nilai perusahaan marang dodolan NVCT

Simbol resmi perusahaan nuvectis.com (NVCT)

Nuvectis Pharma, Inc. (NVCT) specializes in developing targeted therapies for rare oncological diseases, rapidly transitioning licensed molecules into clinical practice. The EV/Sales trend confirms the market valuation of the model, where the 0.00 level serves as a critical benchmark. Unique patents for kinase inhibitors provide a defensive moat for the business, while the efficiency of preclinical stages is increasing through the implementation of laboratory robotics.

Nuvectis Pharma, Inc (NVCT): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Nuvectis - rincian analitis lan metrik utama (NVCT)

Pambiji fundamental perusahaan:NVCT, nuvectis.com
Produk sing diprodhuksi Nuvectis Pharma Inc.

For the biotech Nuvectis Pharma, Inc. (NVCT), this indicator serves as a gauge of market expectations for future revenues. The metric compares the total enterprise value, including debt, against current sales volume. By analyzing the EV/Sales chart, an investor can identify the premium attributed to development potential. However, a lack of asset diversification transforms this ratio into an indicator of binary risk. High values here reflect a speculative bet on the success of two oncology projects.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Coherus BioSciences, Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CRBP (Corbus Pharma)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales